Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03264066
Title A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

renal cell carcinoma

transitional cell carcinoma

head and neck squamous cell carcinoma

Therapies

Atezolizumab + Cabozantinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.